Alexandria Eiken

Employment

• Van Andel Institute Postdoctoral Fellow
  2024 - Present
• University of Nebraska Medical Center Graduate Student
  2018 - 2024

Education

• Northwest Missouri State University Nanoscale Science: Emphasis in Biology
  2014 - 2018

Projects & Funding

Projects & funding information is unavailable.

Publications (6)

• Gut Microbiome Profiling in Eμ-TCL1 Mice Reveals Intestinal Changes and a Dysbiotic Signature Specific to Chronic Lymphocytic Leukemia
  Cancer Research Communications 2025 DOI: 10.1158/2767-9764.CRC-25-0022
  +Save
• Immunogenic Cell Death Traits Emitted from Chronic Lymphocytic Leukemia Cells Following Treatment with a Novel Anti-Cancer Agent, SpiD3
  Elizabeth G. Schmitz, Abigail Ridout, Audrey L. Smith +7 more
  Biomedicines 2024 DOI: 10.3390/biomedicines12122857
  +Save
• The Novel Anti-Cancer Agent, SpiD3, Is Cytotoxic in CLL Cells Resistant to Ibrutinib or Venetoclax
  Alexandria P. Eiken, Elizabeth G. Schmitz, Erin M. Drengler +9 more
  Hemato 2024 DOI: 10.3390/hemato5030024
  +Save
• Novel Spirocyclic Dimer, SpiD3, Targets Chronic Lymphocytic Leukemia Survival Pathways with Potent Preclinical Effects
  Alexandria P. Eiken, Audrey L. Smith, Sydney A. Skupa

  +15 more

  • Elizabeth G. Schmitz
  • Sandeep Rana
  • Sarbjit Singh
  • Siddhartha Kumar
  • Jayapal Reddy Mallareddy
  • +10 more
  Cancer Research Communications 2024 DOI: 10.1158/2767-9764.CRC-24-0071
  +Save
• Editorial for the IJMS Special Issue on Molecular Pathogenesis and Molecular Therapy of Lymphoid Malignancies
  International Journal of Molecular Sciences 2023 DOI: 10.3390/ijms25010557
  +Save
• A Novel Triple-Action Inhibitor Targeting B-Cell Receptor Signaling and BRD4 Demonstrates Preclinical Activity in Chronic Lymphocytic Leukemia
  International Journal of Molecular Sciences 2022 DOI: 10.3390/ijms23126712
  +Save